Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

What Do Hedge Funds Think of Accelerate Diagnostics Inc (AXDX)?

Between June 25 and October 30th the Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by more than 14 percentage points as investors worried over the possible ramifications of rising interest rates. The hedge funds and institutional investors we track typically invest more in smaller-cap stocks than an average investor, and we have seen data that shows those funds paring back their overall exposure. Those funds cutting positions in small-caps is one reason why volatility has increased. In the following paragraphs, we take a closer look at what hedge funds and prominent investors think of Accelerate Diagnostics Inc (NASDAQ:AXDX) and see how the stock is affected by the recent hedge fund activity.

Accelerate Diagnostics Inc (NASDAQ:AXDX) was in 11 hedge funds’ portfolios at the end of September. AXDX shareholders have witnessed a decrease in support from the world’s most elite money managers of late. There were 14 hedge funds in our database with AXDX holdings at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as National Bank Holdings Corp (NYSE:NBHC), Kronos Worldwide, Inc. (NYSE:KRO), and Employers Holdings, Inc. (NYSE:EIG) to gather more data points.

If you’d ask most traders, hedge funds are assumed to be slow, old investment vehicles of years past. While there are more than 8,000 funds in operation at present, We hone in on the masters of this group, approximately 700 funds. These money managers command most of the hedge fund industry’s total capital, and by following their top equity investments, Insider Monkey has uncovered many investment strategies that have historically exceeded the S&P 500 index. Insider Monkey’s small-cap hedge fund strategy surpassed the S&P 500 index by 12 percentage points annually for a decade in their back tests.

Keeping this in mind, let’s analyze the latest action surrounding Accelerate Diagnostics Inc (NASDAQ:AXDX).

What does the smart money think about Accelerate Diagnostics Inc (NASDAQ:AXDX)?

At Q3’s end, a total of 11 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of -21% from the second quarter. With hedgies’ sentiment swirling, there exists a select group of key hedge fund managers who were boosting their holdings substantially (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, Matthew Strobeck’s Birchview Capital has the largest position in Accelerate Diagnostics Inc (NASDAQ:AXDX), worth close to $33.5 million, comprising 20% of its total 13F portfolio. On Birchview Capital’s heels is Miura Global Management, managed by Pasco Alfaro / Richard Tumure, which holds a $9.7 million position; 0.5% of its 13F portfolio is allocated to the stock. Other members of the smart money that hold long positions contain Stewart Strawbridge’s Selkirk Management, Stuart Weisbrod’s Iguana Healthcare Management and Israel Englander’s Millennium Management.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.